Geode Capital Management’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.03M | Sell |
2,319,132
-45,764
| -2% | -$119K | ﹤0.01% | 2637 |
|
|
2025
Q1 | $4.49M | Buy |
2,364,896
+30,725
| +1% | +$58.4K | ﹤0.01% | 2709 |
|
|
2024
Q4 | $3.39M | Buy |
2,334,171
+24,393
| +1% | +$35.4K | ﹤0.01% | 2932 |
|
|
2024
Q3 | $4.25M | Buy |
2,309,778
+19,095
| +0.8% | +$35.1K | ﹤0.01% | 2844 |
|
|
2024
Q2 | $2.29M | Buy |
2,290,683
+215,348
| +10% | +$215K | ﹤0.01% | 3088 |
|
|
2024
Q1 | $4.11M | Buy |
2,075,335
+83,307
| +4% | +$165K | ﹤0.01% | 2803 |
|
|
2023
Q4 | $3.11M | Buy |
1,992,028
+99,707
| +5% | +$156K | ﹤0.01% | 2934 |
|
|
2023
Q3 | $3.73M | Buy |
1,892,321
+84,114
| +5% | +$166K | ﹤0.01% | 2791 |
|
|
2023
Q2 | $5.75M | Buy |
1,808,207
+924,644
| +105% | +$2.94M | ﹤0.01% | 2611 |
|
|
2023
Q1 | $2.89M | Buy |
883,563
+93,315
| +12% | +$305K | ﹤0.01% | 2880 |
|
|
2022
Q4 | $3.97M | Buy |
790,248
+188,924
| +31% | +$950K | ﹤0.01% | 2772 |
|
|
2022
Q3 | $1.37M | Buy |
601,324
+576,467
| +2,319% | +$1.31M | ﹤0.01% | 3235 |
|
|
2022
Q2 | $65K | Hold |
24,857
| – | – | ﹤0.01% | 4713 |
|
|
2022
Q1 | $34K | Buy |
+24,857
| New | +$34K | ﹤0.01% | 4878 |
|